Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Ourense (12)

2024

  1. Cost–Utility Analysis of PCSK9 Inhibitors and Quality of Life: A Two-Year Multicenter Non-Randomized Study

    Diseases, Vol. 12, Núm. 10

2023

  1. Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study

    American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593

  2. Differences in weight loss and safety between the glucagon-like peptide-1 receptor agonists: A non-randomized multicenter study from the titration phase

    Primary Care Diabetes, Vol. 17, Núm. 4, pp. 366-372

  3. Intravenous and topical sodium thiosulfate for treatment of non-uremic calciphylaxis

    Piel

2019

  1. Diverse large HIV-1 non-subtype B clusters are spreading among men who have sex with men in Spain

    Frontiers in Microbiology, Vol. 10, Núm. APR

  2. Prognostic Nomogram and Patterns of Use of FOLFIRI-Aflibercept in Advanced Colorectal Cancer: A Real-World Data Analysis

    Oncologist, Vol. 24, Núm. 8, pp. e687-e695

2015

  1. Another great wannabe..., with fatal outcome

    Revista Clinica Espanola, Vol. 215, Núm. 6, pp. 343-345

2014

  1. Cyclodextrin-polysaccharide-based, in situ-gelled system for ocular antifungal delivery

    Beilstein Journal of Organic Chemistry, Vol. 10, pp. 2903-2911

2011

  1. Tratamiento con rituximab del pénfigo vulgar refractario a terapia convencional

    Atencion Farmaceutica, Vol. 13, Núm. 6, pp. 379-382

2010

  1. Clinical diagnosis of toenail onychomycosis is possible in some patients: Cross-sectional diagnostic study and development of a diagnostic rule

    British Journal of Dermatology, Vol. 163, Núm. 4, pp. 743-751

2009

  1. Toxic epidermal necrolysis (Lyell's syndrome) secondary to alopurinol

    Farmacia Hospitalaria

2003

  1. Muir Torre's syndrome

    Actas Dermo-Sifiliograficas, Vol. 94, Núm. 1, pp. 42-44